Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in gallbladder carcinoma

被引:6
作者
Iwahashi, Shuichi [1 ]
Shimada, Mitsuo [1 ]
Utsunomiya, Tohru [1 ]
Morine, Yuji [1 ]
Imura, Satoru [1 ]
Ikemoto, Tetsuya [1 ]
Mori, Hiroki [1 ]
Hanaoka, Jun [1 ]
机构
[1] Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan
关键词
Thymidylate synthase; Dihydropyrimidine dehydrogenase; 5-Fluorouracil; Gallbladder carcinoma; BILIARY-TRACT CANCERS; HEPATOCELLULAR-CARCINOMA; THYMIDINE PHOSPHORYLASE; COLORECTAL TUMORS; BREAST-CANCER; CHEMOTHERAPY; ADENOCARCINOMA; 5-FLUOROURACIL; FLUOROURACIL; METAPLASIA;
D O I
10.1007/s00595-012-0118-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) are important enzymes in the metabolism of 5-fluorouracil, which have been examined as possible predictive markers. We conducted this study to clarify the role of TS and DPD expressions in gallbladder carcinoma (GBC). Methods The subjects were 28 patients who underwent surgical resection of GBC. We examined intratumoral TS and DPD mRNA expressions, using the Danenberg tumor profile method. The expression levels were classified into two groups, based on median values. Clinicopathological variables, including prognosis, were then compared between the high and low expression groups. Results There was a significant difference in the incidence of lymph node metastasis between the high and low TS expression groups. The incidence of advanced clinical stage was higher in the low TS expression group than in the high TS expression group. However, no clear correlation was observed between the DPD mRNA expression and any clinicopathological variable. There was no significant difference in the postoperative survival rates between the groups, in accordance with the expression of TS or DPD genes. Conclusion Low TS mRNA was correlated with a high incidence of lymph node metastasis and advanced clinical stage. Therefore, TS gene expression may help identify patients at increased risk of the progression of GBC.
引用
收藏
页码:565 / 569
页数:5
相关论文
共 26 条
[1]   Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: A multicenter study [J].
Araida, Tatsuo ;
Higuchi, Ryouta ;
Hamano, Mie ;
Kodera, Yoshihito ;
Takeshita, Nobuhiro ;
Ota, Takehiro ;
Yoshikawa, Tatsuya ;
Yamamoto, Masakazu ;
Takasaki, Ken .
SURGERY TODAY, 2009, 39 (09) :770-779
[2]   Molecular predictors of lymph node metastasis in colon cancer: Increased risk with decreased thymidylate synthase expression [J].
Artinyan, A ;
Essani, R ;
Lake, J ;
Kaiser, AM ;
Vukasin, P ;
Danenberg, P ;
Danenberg, K ;
Haile, R ;
Beart, RW .
JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (09) :1216-1221
[3]   Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers [J].
Baba, H ;
Teramoto, K ;
Kawamura, T ;
Mori, A ;
Imamura, M ;
Arii, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (06) :469-476
[4]   The Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine (PEFG) Regimen in Advanced Biliary Tract Adenocarcinoma [J].
Cereda, Stefano ;
Passoni, Paolo ;
Reni, Michele ;
Vigano, Maria G. ;
Aldrighetti, Luca ;
Nicoletti, Roberto ;
Villa, Eugenio .
CANCER, 2010, 116 (09) :2208-2214
[5]   Medical progress - Biliary tract cancers [J].
de Groen, PC ;
Gores, GJ ;
LaRusso, NF ;
Gunderson, LL ;
Nagorney, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) :1368-1378
[6]   RESPONSE TO FLUOROURACIL THERAPY IN CANCER-PATIENTS - THE ROLE OF TUMORAL DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY [J].
ETIENNE, MC ;
CHERADAME, S ;
FISCHEL, JL ;
FORMENTO, P ;
DASSONVILLE, O ;
RENEE, N ;
SCHNEIDER, M ;
THYSS, A ;
DEMARD, F ;
MILANO, G .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1663-1670
[7]   Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma [J].
R. Fujii ;
A. Seshimo ;
S. Kameoka .
International Journal of Clinical Oncology, 2003, 8 (2) :72-78
[8]   Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer [J].
Fujiwaki, R ;
Hata, K ;
Nakayama, K ;
Fukumoto, M ;
Miyazaki, K .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3946-3951
[9]   Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis [J].
Fukui, Yousuke ;
Oka, Toshinori ;
Nagayama, Sekio ;
Danenberg, Peter V. ;
Danenberg, Kathleen D. ;
Fukushima, Masakazu .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 22 (06) :709-716
[10]   Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy [J].
Ishikawa, Masashi ;
Miyauchi, Takayuki ;
Kashiwagi, Yutaka .
BMC CANCER, 2008, 8 (1)